Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined significantly when compared to the previous year.Adjusted loss was $2.50 per share ...

which MRNA is developing in partnership with Merck (MRK), to lift MRNA stock this year. Ellison's Statement on Potential Cancer Vaccines Last week, Oracle Chairman Larry Ellison asserted that AI ...

This image highlights two alternatives for the ribosome to be recruited to an mRNA that is still being synthesized by RNA polymerase (RNAP). RNAP (left, red) can directly deliver the mRNA to the ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning ... downgrading the stock to equal weight from overweight earlier in the morning. The firm cited "policy risks ...

Investors in Moderna Inc (Symbol: MRNA) saw new options become available today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...

At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new May 16th contracts and identified one put and one call contract of particular interest.

Financial services firm Argus Research is one of those firms with a Hold rating on MRNA stock. "We think that MRNA shares are appropriately valued at recent prices below $45," wrote Argus Research ...

Moderna MRNA shares soared 11.7% in the last trading session to close at $47.53. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...